Picture of Wanjia group logo

401 Wanjia group Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapContrarian

Momentum

Relative Strength (%)
1m+3.36%
3m-20.14%
6m-25.95%
1yr-63.47%
Volume Change (%)
10d/3m-12.66%
Price vs... (%)
52w High-62.05%
50d MA-2.99%
200d MA-28.25%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital2.88%
Return on Equity1.14%
Operating Margin2.05%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Wanjia group EPS forecast chart

Profile Summary

Wanjia Group Holdings Ltd is an investment holding company principally engaged in the pharmaceutical wholesale and distribution business, and hemodialysis treatment and consultancy service business. The Company mainly operates its business through two segments. The Pharmaceutical Wholesale and Distribution Business segment mainly distributes pharmaceutical products for pharmaceutical retail chain stores, independent pharmacies and outpatient departments of community hospitals and healthcare service stations. The Hemodialysis Treatment and Consultancy Service Business segment mainly provides kidney care services and operates hemodialysis treatment centers.

Directors

    Last Annual
    March 31st, 2023
    Last Interim
    September 30th, 2023
    Incorporated
    July 9th, 2012
    Public Since
    October 11th, 2013
    No. of Employees
    198
    Sector
    Healthcare Providers & Services
    Industry
    Healthcare
    Exchange
    hk flag iconStock Exchange of Hong Kong Limited
    Shares in Issue
    560,222,136
    Blurred out image of a map
    Address
    Room 1902
    Web
    https://www.wanjia-gp.com/
    Phone
    +852 null23663375
    Auditors
    HLB Hodgson Impey Cheng

    401 Share Price Performance

    Upcoming Events for 401

    Similar to 401

    Picture of Adicon Holdings logo

    Adicon Holdings

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Aidigong Maternal & Child Health logo

    Aidigong Maternal & Child Health

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Aidigong Maternal & Child Health logo

    Aidigong Maternal & Child Health

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Arrail logo

    Arrail

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Suzhou Basecare Medical logo

    Suzhou Basecare Medical

    hk flag iconStock Exchange of Hong Kong Limited

    FAQ